Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Inventory | -16.41%283.15M | 1.95%337.05M | 0.28%338.73M | -8.37%330.62M | 5.82%337.77M | 61.60%360.82M | 39.73%319.2M | 11.72%223.27M | -7.15%228.43M | -6.58%199.86M |
| Accounts receivable | 5.30%875.81M | 2.83%938.95M | -38.31%831.74M | -28.26%913.08M | -4.06%1.35B | -14.26%1.27B | 9.68%1.41B | 90.15%1.48B | 72.11%1.28B | 11.54%780.59M |
| Advance deposits and other receivables | 0.00%183.5M | -29.58%183.5M | -38.03%183.5M | -4.81%260.57M | 44.77%296.13M | 35.93%273.73M | 25.64%204.55M | 23.64%201.38M | 19.45%162.8M | -2.66%162.88M |
| Cash and equivalents | -26.02%236.67M | -19.18%282.72M | 33.28%319.9M | -19.22%349.79M | -19.44%240.02M | 31.02%433.02M | 18.48%297.93M | 25.43%330.48M | 46.08%251.47M | -18.79%263.49M |
| Financial assets at fair value-current assets | 88.70%140.58M | 111.70%121.49M | 113.32%74.5M | 363.28%57.39M | --34.92M | --12.39M | ---- | ---- | ---- | ---- |
| Special items of current assets | ---- | ---- | ---- | ---- | --94.94M | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -1.64%1.72B | -2.50%1.86B | -25.67%1.75B | -18.75%1.91B | 5.62%2.35B | 5.05%2.35B | 15.75%2.23B | 59.19%2.24B | 47.55%1.92B | 0.09%1.41B |
| Non-current assets | ||||||||||
| Property, plant and equipment | 37.80%2.16B | 30.40%1.99B | 6.12%1.57B | 1.99%1.53B | 10.07%1.48B | -0.01%1.5B | -10.51%1.34B | -0.82%1.5B | 3.72%1.5B | 6.85%1.51B |
| Investment property | -0.03%631.4M | -0.03%631.8M | -1.80%631.6M | -0.78%632M | 0.77%643.2M | 16.26%637M | 15.13%638.3M | -1.07%547.9M | -5.49%554.4M | -6.34%553.8M |
| Advance payment | -82.89%5.37M | -78.43%6.16M | 27.65%31.39M | -15.35%28.57M | -66.91%24.59M | -41.14%33.75M | --74.31M | --57.35M | ---- | ---- |
| Associated company interest | 30.91%1.75M | 28.30%1.77M | --1.33M | --1.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | -6.08%1.6B | -6.17%1.62B | -2.51%1.7B | -2.67%1.72B | -2.72%1.74B | -2.69%1.77B | -2.66%1.79B | -2.78%1.82B | -2.73%1.84B | -2.54%1.87B |
| Deferred tax assets | 25.62%34.47M | 13.09%32.5M | -24.27%27.44M | -27.80%28.74M | 79.13%36.23M | 92.61%39.8M | -1.20%20.23M | 129.97%20.66M | 132.89%20.47M | -6.40%8.99M |
| Total non-current assets | 11.41%4.59B | 8.27%4.43B | 0.85%4.12B | -0.07%4.1B | 2.31%4.09B | 0.64%4.1B | -1.43%3.99B | -0.25%4.07B | -0.01%4.05B | 0.71%4.08B |
| Total assets | 7.52%6.31B | 4.85%6.3B | -8.84%5.87B | -6.88%6.01B | 3.49%6.44B | 2.21%6.45B | 4.10%6.22B | 14.98%6.31B | 11.57%5.98B | 0.55%5.49B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | -13.79%629.46M | -3.29%807.14M | -8.25%730.12M | -18.60%834.59M | -17.65%795.76M | -12.51%1.03B | -5.23%966.34M | 95.73%1.17B | 98.59%1.02B | 14.71%598.77M |
| Tax payable | 4.62%71.38M | -9.76%74.56M | -36.22%68.22M | -35.34%82.63M | -13.97%106.96M | -4.13%127.8M | -20.45%124.32M | -0.06%133.31M | 15.75%156.28M | -13.73%133.39M |
| Bank loans and overdrafts | 1.72%906.65M | 4.07%894.09M | 39.20%891.34M | -6.37%859.1M | -29.04%640.33M | 29.90%917.54M | 47.64%902.37M | 26.59%706.34M | 24.73%611.19M | -7.61%557.99M |
| Financial lease liabilities-current liabilities | -25.81%3.66M | -41.75%2.76M | 20.26%4.93M | -10.86%4.74M | -37.83%4.1M | -24.20%5.31M | 0.38%6.6M | -7.20%7.01M | -9.24%6.57M | 10.98%7.55M |
| Special items of current liabilities | ---- | ---- | ---- | ---- | --20.46M | ---- | ---- | ---- | ---- | ---- |
| Total current liabilities | -4.11%1.65B | 0.34%1.82B | -1.75%1.72B | -16.30%1.81B | -15.68%1.75B | 2.99%2.16B | 14.58%2.08B | 56.39%2.1B | 52.54%1.82B | -1.25%1.34B |
| Net current assets | 170.09%67.03M | -53.58%46.71M | -95.85%24.82M | -46.83%100.62M | 307.90%597.85M | 36.31%189.26M | 35.39%146.57M | 118.27%138.84M | -4.68%108.26M | 40.33%63.61M |
| Total assets less current liabilities | 12.36%4.66B | 6.79%4.48B | -11.49%4.15B | -2.14%4.2B | 13.12%4.68B | 1.82%4.29B | -0.48%4.14B | 1.57%4.21B | -0.14%4.16B | 1.15%4.15B |
| Non-current liabilities | ||||||||||
| Long-term bank loan | 79.39%1.13B | 37.31%955.9M | -40.16%631.6M | -6.97%696.16M | 93.29%1.06B | 8.52%748.34M | -28.88%546.09M | -22.56%689.62M | -15.09%767.79M | -0.62%890.54M |
| Financial lease liabilities-non-current liabilities | 52.66%11.7M | 221.64%7.12M | 73.35%7.66M | -65.28%2.21M | -48.13%4.42M | -46.35%6.38M | -41.67%8.52M | -31.60%11.88M | -24.22%14.61M | -23.02%17.38M |
| Deferred tax liability | 10.46%67.43M | -14.00%73.9M | -26.04%61.04M | -9.80%85.92M | -18.39%82.53M | -0.85%95.25M | -8.62%101.13M | -11.46%96.07M | -3.11%110.68M | -8.86%108.51M |
| Deferred income-non-current liabilities | -2.07%34.39M | -2.24%34.72M | -2.24%35.12M | -2.22%35.52M | -3.17%35.92M | -2.17%36.32M | 3,666.19%37.1M | 1,519.90%37.13M | -57.60%985K | -24.95%2.29M |
| Other non-current liabilities | ---- | ---- | ---- | ---- | -0.92%141.84M | -32.66%139.22M | -23.35%143.16M | 10.58%206.73M | -34.96%186.76M | -37.93%186.94M |
| Total non-current liabilities | 69.50%1.25B | 30.72%1.07B | -44.30%735.42M | -20.06%819.81M | 57.93%1.32B | -1.53%1.03B | -22.65%836M | -13.62%1.04B | -18.57%1.08B | -10.16%1.21B |
| Total liabilities | 17.90%2.9B | 9.81%2.89B | -20.02%2.46B | -17.51%2.63B | 5.42%3.07B | 1.49%3.19B | 0.69%2.92B | 23.27%3.14B | 15.05%2.9B | -5.67%2.55B |
| Total assets less total liabilities | 0.03%3.41B | 0.98%3.41B | 1.39%3.41B | 3.50%3.38B | 1.79%3.36B | 2.92%3.26B | 7.31%3.3B | 7.80%3.17B | 8.48%3.08B | 6.66%2.94B |
| Total equity and non-current liabilities | 12.36%4.66B | 6.79%4.48B | -11.49%4.15B | -2.14%4.2B | 13.12%4.68B | 1.82%4.29B | -0.48%4.14B | 1.57%4.21B | -0.14%4.16B | 1.15%4.15B |
| Equity | ||||||||||
| Share capital | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 0.00%101.52M | 19.87%101.52M |
| Share premium | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 39.56%1.29B |
| Other reserves | 11.12%505.82M | 10.25%502.55M | 6.21%455.2M | 9.28%455.81M | 14.29%428.57M | 9.30%417.1M | 3.45%375M | 7.89%381.62M | 11.33%362.51M | 7.18%353.72M |
| Retained profit | -6.56%1.24B | -2.50%1.25B | 7.46%1.32B | 9.68%1.28B | -0.30%1.23B | 2.39%1.16B | 14.20%1.23B | 16.41%1.14B | 14.67%1.08B | 11.34%977.13M |
| Special items of shareholders' rights and interests | -26.00%-979K | ---979K | ---777K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders' Equity | -1.14%3.13B | 0.44%3.14B | 3.85%3.17B | 5.09%3.13B | 1.66%3.05B | 2.15%2.98B | 5.85%3B | 6.91%2.91B | 6.58%2.84B | 4.74%2.72B |
| Non-controlling interest | 15.57%277.61M | 7.73%268.32M | -22.81%240.22M | -13.04%249.07M | 3.09%311.21M | 11.64%286.43M | 24.37%301.87M | 19.04%256.55M | 37.05%242.72M | 38.76%215.53M |
| Total equity | 0.03%3.41B | 0.98%3.41B | 1.39%3.41B | 3.50%3.38B | 1.79%3.36B | 2.92%3.26B | 7.31%3.3B | 7.80%3.17B | 8.48%3.08B | 6.66%2.94B |
| Total equity and total liabilities | 7.52%6.31B | 4.85%6.3B | -8.84%5.87B | -6.88%6.01B | 3.49%6.44B | 2.21%6.45B | 4.10%6.22B | 14.98%6.31B | 11.57%5.98B | 0.55%5.49B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.